Community-acquired pneumonia (CAP) is the leading cause of death among infectious
diseases and an important health problem, having considerable implications for healthcare …

Azithromycin is a macrolide antibiotic which inhibits bacterial protein synthesis, quorum-
sensing and reduces the formation of biofilm. Accumulating effectively in cells, particularly …

Despite extensive global efforts in the fight against killer infectious diseases, they still cause
one in four deaths worldwide and are important causes of long-term functional disability …

Macrolides have diverse biological activities and an ability to modulate inflammation and
immunity in eukaryotes without affecting homeostatic immunity. These properties have led to …

Objective To assess the effect on survival of macrolides or fluoroquinolones in intubated
patients admitted to the intensive care unit (ICU) with severe community-acquired …

Objective: Some studies suggest better outcomes with macrolide therapy for critically ill
patients with community-acquired pneumonia. To further explore this, we performed a …

Importance Although clinical practice guidelines recommend combination therapy with
macrolides, including azithromycin, as first-line therapy for patients hospitalized with …

Pneumonia remains the leading cause of childhood mortality and the most common reason
for adult hospitalisation in low and middle income countries, despite advances in …

Community‐acquired pneumonia (CAP) is an important cause of death around the globe.
Up to 30% of patients admitted to hospital for CAP develop cardiovascular complications (ie …

Community-acquired pneumonia continues to have a significant impact on elderly
individuals, who are affected more frequently and with more severe consequences than …